Yu KD - Search Results

1

A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer.

Jin X, Jiang YZ, Chen S, Yu KD, Ma D, Sun W, Shao ZM, Di GH. Jin X, et al. Among authors: yu kd. BMC Cancer. 2016 Aug 5;16:606. doi: 10.1186/s12885-016-2652-z. BMC Cancer. 2016. PMID: 27495967 Free PMC article.

2

Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.

Yu KD, Liu GY, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Yu KD, et al. Breast. 2007 Jun;16(3):307-15. doi: 10.1016/j.breast.2006.12.011. Epub 2007 Feb 12. Breast. 2007. PMID: 17293115

3

Development and trends of surgical modalities for breast cancer in China: a review of 16-year data.

Yu KD, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Yu KD, et al. Ann Surg Oncol. 2007 Sep;14(9):2502-9. doi: 10.1245/s10434-007-9436-2. Epub 2007 Jun 13. Ann Surg Oncol. 2007. PMID: 17564750

4

[Surgical management of early breast cancer].

Di GH, Wu J, Yu KD, Lu JS, Shen KW, Shen ZZ, Shao ZM. Di GH, et al. Among authors: yu kd. Zhonghua Zhong Liu Za Zhi. 2007 Jan;29(1):62-5. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17575698 Chinese.

5

Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment.

Yu KD, Di GH, Wu J, Lu JS, Shen KW, Liu GY, Shen ZZ, Shao ZM. Yu KD, et al. J Cancer Res Clin Oncol. 2008 Dec;134(12):1347-54. doi: 10.1007/s00432-008-0414-2. Epub 2008 May 17. J Cancer Res Clin Oncol. 2008. PMID: 18488249

6

A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.

Yu KD, Di GH, Fan L, Wu J, Hu Z, Shen ZZ, Huang W, Shao ZM. Yu KD, et al. FASEB J. 2009 Jul;23(7):2274-87. doi: 10.1096/fj.08-124073. Epub 2009 Feb 19. FASEB J. 2009. PMID: 19228880

7

Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53.

Yu KD, Di GH, Yuan WT, Fan L, Wu J, Hu Z, Shen ZZ, Zheng Y, Huang W, Shao ZM. Yu KD, et al. Hum Mol Genet. 2009 Jul 1;18(13):2502-17. doi: 10.1093/hmg/ddp171. Epub 2009 Apr 7. Hum Mol Genet. 2009. PMID: 19351655

8

Caution regarding genotyping methodology for a tri-allelic polymorphism in the novel breast cancer susceptibility gene NQO2.

Yu KD, Di GH, Fan L, Hu Z, Chen AX, Shao ZM. Yu KD, et al. Breast Cancer Res Treat. 2009 Dec;118(3):647-9. doi: 10.1007/s10549-009-0431-0. Epub 2009 Jun 3. Breast Cancer Res Treat. 2009. PMID: 19495956 No abstract available.

9

Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.

Yu KD, Di GH, Li WF, Rao NY, Fan L, Yuan WT, Hu Z, Wu J, Shen ZZ, Huang W, Shao ZM. Yu KD, et al. Breast Cancer Res Treat. 2010 May;121(1):157-67. doi: 10.1007/s10549-009-0516-9. Epub 2009 Sep 2. Breast Cancer Res Treat. 2010. PMID: 19728081

10

Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1.

Yu KD, Fan L, Di GH, Yuan WT, Zheng Y, Huang W, Chen AX, Yang C, Wu J, Shen ZZ, Shao ZM. Yu KD, et al. Breast Cancer Res Treat. 2010 Jun;121(2):485-96. doi: 10.1007/s10549-009-0585-9. Epub 2009 Oct 24. Breast Cancer Res Treat. 2010. PMID: 19856098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters